ONCHealthcareLarge-Cap

BeOne Medicines Ltd. Insider Trading Activity

Every SEC Form 4 insider transaction reported for BeOne Medicines Ltd. (ONC), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are ONC insiders buying or selling?

BeOne Medicines Ltd. insiders reported 3 open-market buys ($877.9M) and 289 sells ($6.4B) across 292 Form 4 filings — a net selling position of $5.5B.

Source: SEC EDGAR Form 4

Key Statistics (as of Aug 27, 2026)

Total Form 4 filings
292
SEC EDGAR
Insider filers
21
Insider buys (3)
$877.9M
Insider sells (289)
$6.4B

Insider sentiment

Net selling

Net insider flow of $5.5B in net selling.

Recent ONC insider transactions

DateInsiderRoleTypeSharesPriceValue
Aug 27, 2026Xiaobin WuPresident and COOSale280$380.00$106.4K
Aug 14, 2026Chan Henry LeeSVP, General CounselSale2.7K$360.00$959.8K
Aug 12, 2026John OylerChief Executive OfficerSale240.8K$359.12$86.5M
Aug 5, 2026Aaron RosenbergChief Financial OfficerSale1.2K$312.71$361.8K
Aug 3, 2026Chan Henry LeeSVP, General CounselSale1.0K$323.69$337.9K
Jul 24, 2026Chan Henry LeeSVP, General CounselSale1.7K$325.00$542.4K
Jul 17, 2026John OylerChief Executive OfficerSale64.6K$312.00$20.2M
Jul 17, 2026John OylerChief Executive OfficerSale283.2K$315.56$89.4M
Jul 15, 2026John OylerChief Executive OfficerSale145.9K$305.95$44.6M
Jul 15, 2026John OylerChief Executive OfficerSale60.2K$303.18$18.3M
Jun 25, 2026Xiaobin WuPresident and COOSale1.3K$276.26$356.9K
Jun 25, 2026John OylerChief Executive OfficerSale3.4K$273.78$933.6K
Jun 25, 2026Lai WangPresident, Global Head of R&DSale1.1K$276.74$295.6K
Jun 18, 2026Xiaobin WuPresident and COOSale1.4K$266.76$362.0K
Jun 18, 2026John OylerChief Executive OfficerSale3.7K$265.55$980.7K
Jun 18, 2026Chan Henry LeeSVP, General CounselSale590$265.98$156.9K
Jun 18, 2026Lai WangPresident, Global Head of R&DSale1.2K$265.39$310.2K
Jun 15, 2026Titus B. BallPrincipal Accounting OfficerSale169$257.20$43.5K
Jun 15, 2026Lai WangPresident, Global Head of R&DSale756$261.00$197.3K
Jun 15, 2026Aaron RosenbergChief Financial OfficerSale631$257.74$162.6K
Jun 15, 2026Xiaobin WuPresident and COOSale626$261.20$163.5K
Jun 15, 2026Chan Henry LeeSVP, General CounselSale428$257.64$110.3K
Jun 15, 2026John OylerChief Executive OfficerSale1.9K$257.24$501.4K
Jun 10, 2026Titus B. BallPrincipal Accounting OfficerSale136$271.33$36.9K
Jun 10, 2026Chan Henry LeeSVP, General CounselSale871$270.42$235.5K

Showing the 25 most recent of 292 Form 4 filings for BeOne Medicines Ltd..

Most active ONC insiders

  • John Oyler58 filings
  • Jane Huang43 filings
  • Xiaobin Wu40 filings
  • Xiaodong Wang38 filings
  • Chan Henry Lee25 filings

Ask anything about ONC insider activity

Use Trabud's AI agent to query BeOne Medicines Ltd.'s Form 4 history in plain English — "Show me ONC CEO purchases this year" or compare it against any other ticker.

Open the AI agent

ONC insider trading FAQ

Are BeOne Medicines Ltd. insiders buying or selling?

Across 292 SEC Form 4 filings, BeOne Medicines Ltd. (ONC) insiders reported 3 open-market purchases totaling $877.9M and 289 sales totaling $6.4B. That is a net selling position of $5.5B.

How many insiders trade ONC stock?

21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for BeOne Medicines Ltd.. The most recent filing was accepted on Aug 27, 2026.

Where does Trabud get ONC insider trading data?

All ONC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content